2022 Q3 Form 10-Q Financial Statement
#000149315222022084 Filed on August 11, 2022
Income Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|
Balance Sheet
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $13.29M | $15.76M | $20.34M |
YoY Change | -43.79% | -40.27% | -26.71% |
Cash & Equivalents | $13.29M | $15.76M | $20.34M |
Short-Term Investments | |||
Other Short-Term Assets | $1.018M | $1.317M | $1.347M |
YoY Change | 92.08% | 53.32% | 10.41% |
Inventory | $1.014M | $1.038M | $700.0K |
Prepaid Expenses | |||
Receivables | $161.0K | $81.00K | $18.00K |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $15.49M | $18.19M | $22.40M |
YoY Change | -37.75% | -35.06% | -24.85% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $1.395M | $1.329M | $2.009M |
YoY Change | -36.21% | -38.56% | -1.52% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $13.00K | $13.00K | $13.00K |
YoY Change | 0.0% | 0.0% | 30.0% |
Total Long-Term Assets | $1.879M | $1.889M | $2.022M |
YoY Change | -14.59% | -13.19% | -1.84% |
TOTAL ASSETS | |||
Total Short-Term Assets | $15.49M | $18.19M | $22.40M |
Total Long-Term Assets | $1.879M | $1.889M | $2.022M |
Total Assets | $17.37M | $20.08M | $24.43M |
YoY Change | -35.87% | -33.49% | -23.36% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.696M | $2.212M | $1.992M |
YoY Change | 15.36% | 2.88% | -1.39% |
Accrued Expenses | $248.0K | $266.0K | $296.0K |
YoY Change | -17.33% | 1.92% | 23.33% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | $2.453M | $1.757M | $1.083M |
YoY Change | -77.99% | -86.43% | |
Total Short-Term Liabilities | $5.467M | $4.253M | $3.379M |
YoY Change | 106.61% | -59.11% | -67.0% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $5.251M | $5.892M | $10.36M |
YoY Change | -37.68% | ||
Other Long-Term Liabilities | $2.009M | $2.103M | $2.077M |
YoY Change | -9.75% | -4.45% | -5.59% |
Total Long-Term Liabilities | $5.251M | $5.892M | $12.44M |
YoY Change | -50.7% | 167.7% | 465.41% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.467M | $4.253M | $3.379M |
Total Long-Term Liabilities | $5.251M | $5.892M | $12.44M |
Total Liabilities | $16.60M | $16.11M | $15.82M |
YoY Change | 24.86% | 27.84% | 27.15% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$137.7M | -$132.7M | |
YoY Change | |||
Common Stock | $0.00 | $0.00 | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $762.0K | $3.972M | $8.606M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $17.37M | $20.08M | $24.43M |
YoY Change | -35.87% | -33.49% | -23.36% |
Cashflow Statement
Concept | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001686850 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2021Q2 | mots |
Cost Of Revenue Impairment Of Inventory
CostOfRevenueImpairmentOfInventory
|
usd | |
mots |
Cost Of Revenue Impairment Of Inventory
CostOfRevenueImpairmentOfInventory
|
usd | ||
CY2022Q2 | mots |
Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
|
usd | |
CY2021Q2 | mots |
Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
|
usd | |
mots |
Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
|
usd | ||
CY2022Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
CY2022Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
|
usd | |
mots |
Provision For Excess And Obsolete Inventory
ProvisionForExcessAndObsoleteInventory
|
usd | ||
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
usd | ||
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
usd | ||
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
usd | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
usd | ||
mots |
Proceeds From Issuance Of Common Shares Pursuant To Atthemarket Issuance Registered Offering
ProceedsFromIssuanceOfCommonSharesPursuantToAtthemarketIssuanceRegisteredOffering
|
usd | ||
us-gaap |
Stock Issued1
StockIssued1
|
usd | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
usd | ||
mots |
Prepaid In Addition On Lease Rightofuse Aset
PrepaidInAdditionOnLeaseRightofuseAset
|
usd | ||
CY2021Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
usd | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
pure | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-38389 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Motus GI Holdings, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
81-4042793 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1301 East Broward Boulevard | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
3rd Floor | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Ft. Lauderdale | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33301 | ||
dei |
City Area Code
CityAreaCode
|
(954) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
541 8000 | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
2996837 | shares |
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value per share | ||
dei |
Trading Symbol
TradingSymbol
|
MOTS | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15757000 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22563000 | usd |
CY2022Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
81000 | usd |
CY2021Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
109000 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
1038000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
496000 | usd |
CY2022Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1317000 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
793000 | usd |
CY2022Q2 | us-gaap |
Assets Current
AssetsCurrent
|
18193000 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
23961000 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1329000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1428000 | usd |
CY2022Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
547000 | usd |
CY2022Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
13000 | usd |
CY2022Q2 | us-gaap |
Assets
Assets
|
20082000 | usd |
CY2022Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2212000 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
266000 | usd |
CY2022Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
18000 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
270000 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
271000 | usd |
CY2022Q2 | us-gaap |
Long Term Debt Current
LongTermDebtCurrent
|
1757000 | usd |
CY2022Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4253000 | usd |
CY2022Q2 | mots |
Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
|
1823000 | usd |
CY2021Q4 | mots |
Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
|
1760000 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
280000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
385000 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
138000 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
|
166000 | usd |
CY2022Q2 | mots |
Convertible Note Noncurrent
ConvertibleNoteNoncurrent
|
3862000 | usd |
CY2021Q4 | mots |
Convertible Note Noncurrent
ConvertibleNoteNoncurrent
|
3834000 | usd |
CY2022Q2 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
221000 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
|
317000 | usd |
CY2022Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5750000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
5750000 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2765259 | shares |
CY2022Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2765259 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
2416021 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
2416021 | shares |
CY2022Q2 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
5892000 | usd |
CY2021Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
7121000 | usd |
CY2022Q2 | us-gaap |
Liabilities
Liabilities
|
16110000 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
16432000 | usd |
CY2022Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
136677000 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
132411000 | usd |
CY2022Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-132705000 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-122754000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3972000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9657000 | usd |
CY2022Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
20082000 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
26089000 | usd |
CY2022Q2 | us-gaap |
Revenues
Revenues
|
185000 | usd |
CY2021Q2 | us-gaap |
Revenues
Revenues
|
100000 | usd |
us-gaap |
Revenues
Revenues
|
205000 | usd | |
us-gaap |
Revenues
Revenues
|
151000 | usd | |
CY2022Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
68000 | usd |
CY2021Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
42000 | usd |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
83000 | usd | |
us-gaap |
Cost Of Revenue
CostOfRevenue
|
70000 | usd | |
mots |
Cost Of Revenue Impairment Of Inventory
CostOfRevenueImpairmentOfInventory
|
159000 | usd | |
CY2022Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1413000 | usd |
CY2021Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1508000 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2688000 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2853000 | usd | |
CY2022Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1222000 | usd |
CY2021Q2 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
795000 | usd |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
2205000 | usd | |
us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1471000 | usd | |
CY2022Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2075000 | usd |
CY2021Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2345000 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4189000 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4789000 | usd | |
CY2022Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
4778000 | usd |
CY2021Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
4690000 | usd |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
9324000 | usd | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
9183000 | usd | |
CY2022Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4593000 | usd |
CY2021Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4590000 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9119000 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9032000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-9951000 | usd | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-15536000 | usd | |
CY2022Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.86 | |
CY2022Q2 | mots |
Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
|
-92000 | usd |
CY2021Q2 | mots |
Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
|
-37000 | usd |
mots |
Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
|
-63000 | usd | |
mots |
Gain Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
GainLossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
|
-117000 | usd | |
CY2022Q2 | mots |
Finance Income Expense Net
FinanceIncomeExpenseNet
|
-359000 | usd |
CY2021Q2 | mots |
Finance Income Expense Net
FinanceIncomeExpenseNet
|
-117000 | usd |
mots |
Finance Income Expense Net
FinanceIncomeExpenseNet
|
-691000 | usd | |
mots |
Finance Income Expense Net
FinanceIncomeExpenseNet
|
-234000 | usd | |
CY2022Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-96000 | usd |
CY2021Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
2000 | usd |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-78000 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-8000 | usd | |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5140000 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4742000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-9951000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-9391000 | usd | |
mots |
Deemed Dividends From Warrant Issuance
DeemedDividendsFromWarrantIssuance
|
6145000 | usd | |
CY2022Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-5140000 | usd |
CY2021Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-4742000 | usd |
CY2021Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.99 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-3.72 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-6.83 | ||
CY2022Q2 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
2758457 | shares |
CY2021Q2 | us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
2386633 | shares |
us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
2674536 | shares | |
us-gaap |
Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
|
2274688 | shares | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9657000 | usd |
CY2022Q1 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
111000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
3004000 | usd |
CY2022Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
235000 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
521000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4811000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
8606000 | usd |
CY2022Q2 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
5000 | usd |
CY2022Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
45000 | usd |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
461000 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-5140000 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3972000 | usd |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
11290000 | usd |
CY2021Q1 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
366000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
11593000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
11593000 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
272000 | usd |
mots |
Issuance Of Common Stock For Board Of Directors Compensation
IssuanceOfCommonStockForBoardOfDirectorsCompensation
|
114000 | usd | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
53000 | usd | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
919000 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4649000 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19425000 | usd |
CY2021Q2 | us-gaap |
Payments Of Financing Costs
PaymentsOfFinancingCosts
|
74000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1826000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1826000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
19000 | usd |
CY2021Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
53000 | usd |
CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1010000 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4742000 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17591000 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-9951000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-9391000 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
253000 | usd | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
200000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
125000 | usd | |
us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
4000 | usd | |
mots |
Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
|
-63000 | usd | |
mots |
Loss On Change In Estimated Fair Value Of Contingent Royalty Obligation
LossOnChangeInEstimatedFairValueOfContingentRoyaltyObligation
|
-117000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
982000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1929000 | usd | |
mots |
Provision For Excess And Obsolete Inventory
ProvisionForExcessAndObsoleteInventory
|
159000 | usd | |
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
36000 | usd | |
mots |
Issuance Of Common Stock For Board Of Directors Compensation
IssuanceOfCommonStockForBoardOfDirectorsCompensation
|
118000 | usd | |
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
175000 | usd | |
us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
54000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-28000 | usd | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
38000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
764000 | usd | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-43000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
407000 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
366000 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-459000 | usd | |
us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-204000 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-177000 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-57000 | usd | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
8000 | usd | |
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-53000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9811000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-7595000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
49000 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
269000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-49000 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-269000 | usd | |
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
34000 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
11959000 | usd | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
1901000 | usd | |
mots |
Proceeds From Issuance Of Common Shares Pursuant To Atthemarket Issuance Registered Offering
ProceedsFromIssuanceOfCommonSharesPursuantToAtthemarketIssuanceRegisteredOffering
|
3165000 | usd | |
mots |
Payments Of Financing Fees
PaymentsOfFinancingFees
|
111000 | usd | |
mots |
Payments Of Financing Fees
PaymentsOfFinancingFees
|
436000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
3054000 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
13424000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-6806000 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
5560000 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
22563000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
20819000 | usd |
CY2022Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
15757000 | usd |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
26379000 | usd |
us-gaap |
Interest Paid Net
InterestPaidNet
|
511000 | usd | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
222000 | usd | |
us-gaap |
Stock Issued1
StockIssued1
|
56000 | usd | |
mots |
Common Stock Issued For Prepaid Board Of Directors Compensation
CommonStockIssuedForPrepaidBoardOfDirectorsCompensation
|
117000 | usd | |
mots |
Common Stock Issued For Prepaid Board Of Directors Compensation
CommonStockIssuedForPrepaidBoardOfDirectorsCompensation
|
121000 | usd | |
mots |
Reclassification Of Prepaid Expenses To Fixed Assets
ReclassificationOfPrepaidExpensesToFixedAssets
|
4000 | usd | |
mots |
Reclassification Of Prepaid Expenses To Fixed Assets
ReclassificationOfPrepaidExpensesToFixedAssets
|
75000 | usd | |
mots |
Reclassification Of Inventory To Fixed Assets
ReclassificationOfInventoryToFixedAssets
|
62000 | usd | |
mots |
Reclassification Of Inventory To Fixed Assets
ReclassificationOfInventoryToFixedAssets
|
56000 | usd | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
75000 | usd | |
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
73000 | usd | |
mots |
Financing Fees Included In Accounts Payable And Accrued Expenses
FinancingFeesIncludedInAccountsPayableAndAccruedExpenses
|
5000 | usd | |
mots |
Financing Fees Included In Accounts Payable And Accrued Expenses
FinancingFeesIncludedInAccountsPayableAndAccruedExpenses
|
4000 | usd | |
mots |
Prepaid In Addition On Lease Rightofuse Aset
PrepaidInAdditionOnLeaseRightofuseAset
|
3000 | usd | |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<p id="xdx_80E_eus-gaap--NatureOfOperations_zhMWb3zbaHmd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1 – <span id="xdx_820_zB9pWhvDfzw2">Description of Business</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Motus GI Holdings, Inc. (the “Company”) was incorporated in Delaware, U.S.A. in September 2016. The Company and its subsidiaries, Motus GI Technologies, Ltd. and Motus GI, LLC, are collectively referred to as “Motus GI” or the “Company”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the “FDA”) to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal (“GI”) endoscopy procedures. The Pure-Vu System has received a CE Mark in the EU for use in colonoscopy. The Pure-Vu System integrates with standard and slim colonoscopes, as well as gastroscopes, to improve visualization during colonoscopy and upper GI procedures while preserving established procedural workflow and techniques. Through irrigation and evacuation of debris, the Pure-Vu System is designed to provide better-quality exams. The Company received 510(k) clearance in February 2022 from the FDA for its Pure-Vu EVS System and recently commenced commercialization of this product.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-9811000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-9951000 | usd | |
CY2022Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15757000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_843_eus-gaap--UseOfEstimates_zUurZhDbMQo5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2021Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
569000 | usd |
CY2022Q2 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
68000 | usd |
CY2022Q2 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
670000 | usd |
CY2021Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
292000 | usd |
CY2022Q2 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
50000 | usd |
us-gaap |
Servicing Liability At Fair Value Description Of Other Changes In Fair Value
ServicingLiabilityAtFairValueDescriptionOfOtherChangesInFairValue
|
The Company recalculated the fair value of the liability by applying a +/- 2% change to the input variable in the discounted cash flow model; the discount rate. A 2% decrease in the discount rate would increase the liability by $137 and a 2% increase in the discount rate would decrease the liability by $125. | ||
CY2022Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | usd |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
159000 | usd | |
us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | usd | |
CY2021Q2 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
0 | usd |
CY2022Q2 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
350000 | usd |
CY2021Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
365000 | usd |
CY2022Q2 | us-gaap |
Inventory Net
InventoryNet
|
1038000 | usd |
CY2021Q4 | us-gaap |
Inventory Net
InventoryNet
|
496000 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2955000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
2818000 | usd |
CY2022Q2 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1626000 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1390000 | usd |
CY2022Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1329000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
1428000 | usd |
CY2022Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
129000 | usd |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
253000 | usd | |
CY2022Q2 | us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
36000 | usd |
us-gaap |
Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
|
36000 | usd | |
CY2021Q2 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
102000 | usd |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
200000 | usd | |
us-gaap |
Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
|
Certain operating leases include escalation clauses and some of which may include options to extend the leases for up to 3 years. | ||
CY2022Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
23000 | usd |
CY2021Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
32000 | usd |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
62000 | usd | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
64000 | usd | |
CY2022Q2 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
30000 | usd |
CY2021Q2 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
30000 | usd |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
60000 | usd | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
60000 | usd | |
CY2022Q2 | us-gaap |
Lease Cost
LeaseCost
|
53000 | usd |
CY2021Q2 | us-gaap |
Lease Cost
LeaseCost
|
62000 | usd |
us-gaap |
Lease Cost
LeaseCost
|
122000 | usd | |
us-gaap |
Lease Cost
LeaseCost
|
124000 | usd | |
CY2022Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
547000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
687000 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
266000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
307000 | usd |
mots |
Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
|
117000 | usd | |
us-gaap |
Manufacturing Costs
ManufacturingCosts
|
285000 | usd | |
us-gaap |
Severance Costs1
SeveranceCosts1
|
1428000 | usd | |
CY2022Q2 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
280000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
385000 | usd |
CY2022Q2 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
546000 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
692000 | usd |
CY2022Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y1M2D | |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y5M26D | |
CY2022Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0744 | pure |
CY2021Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0766 | pure |
CY2022Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
53000 | usd |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
122000 | usd | |
CY2022Q2 | us-gaap |
Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
|
60000 | usd |
us-gaap |
Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
|
107000 | usd | |
CY2021Q2 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
62000 | usd |
us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
124000 | usd | |
CY2021Q2 | us-gaap |
Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
|
47000 | usd |
us-gaap |
Direct Taxes And Licenses Costs
DirectTaxesAndLicensesCosts
|
94000 | usd | |
us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
540000 | usd | |
us-gaap |
Interest Expense Other
InterestExpenseOther
|
535000 | usd | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
125000 | usd | |
us-gaap |
Interest Expense
InterestExpense
|
660000 | usd | |
CY2022Q2 | us-gaap |
Interest Expense Other
InterestExpenseOther
|
291000 | usd |
CY2022Q2 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
65000 | usd |
CY2022Q2 | us-gaap |
Interest Expense
InterestExpense
|
356000 | usd |
us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
1332000 | usd | |
CY2022Q2 | mots |
London Interbank Offered Rate
LondonInterbankOfferedRate
|
1424000 | usd |
CY2021Q4 | mots |
London Interbank Offered Rate
LondonInterbankOfferedRate
|
1419000 | usd |
mots |
Royalties Percentage
RoyaltiesPercentage
|
0.04 | pure | |
mots |
Net Sales Percentage
NetSalesPercentage
|
0.03 | pure | |
mots |
Licensing Percentage
LicensingPercentage
|
0.05 | pure | |
us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
30000000 | usd | |
us-gaap |
Proceeds From Royalties Received
ProceedsFromRoyaltiesReceived
|
30000000 | usd | |
CY2022Q2 | mots |
Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
|
1823000 | usd |
CY2021Q4 | mots |
Contingent Royalty Obligation Non Current
ContingentRoyaltyObligationNonCurrent
|
1760000 | usd |
CY2022Q2 | mots |
Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
|
92000 | usd |
mots |
Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
|
63000 | usd | |
CY2021Q2 | mots |
Loss On Change In Fair Value Of Contingent Royalty Obligation
LossOnChangeInFairValueOfContingentRoyaltyObligation
|
37000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0204 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0073 | pure | |
CY2022Q2 | mots |
License Fees
LicenseFees
|
60000 | usd |
mots |
License Fees
LicenseFees
|
107000 | usd | |
CY2021Q2 | mots |
License Fees
LicenseFees
|
47000 | usd |
mots |
License Fees
LicenseFees
|
94000 | usd | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost
|
26000 | usd | |
CY2021Q1 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
11000000 | usd |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
394577 | shares | |
CY2022Q2 | mots |
Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
|
50.87 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
307592 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
54.10 | |
mots |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
|
P7Y5M12D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
98747 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
8.98 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
75 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
36.77 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
2353 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
12.17 | ||
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
403911 | shares |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
43.34 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y6M29D | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y9M3D | ||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y9M | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.9931 | pure | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.0676 | pure | |
CY2022Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.0 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
8.80 | ||
CY2022Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
461000 | usd |
CY2021Q2 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1010000 | usd |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
982000 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1929000 | usd |